Singapore markets open in 6 hours 12 minutes
Straits Times Index
3,322.08 -8.69 (-0.26%) S&P 500
5,357.14 +10.15 (+0.19%) Dow
38,841.45 +42.46 (+0.11%) Nasdaq
17,173.38 +40.26 (+0.23%) Bitcoin USD
69,887.34 +184.16 (+0.26%) CMC Crypto 200
1,448.12 +1.45 (+0.10%)
LLY Oct 2024 750.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:03PM EDT. Market open.
| Previous close | 120.45 |
| Open | 109.50 |
| Bid | 135.70 |
| Ask | 138.15 |
| Strike | 750.00 |
| Expiry date | 2024-10-18 |
| Day's range | 109.50 - 120.45 |
| Contract range | N/A |
| Volume | |
| Open interest | 86 |
Yahoo FinanceEli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
ZacksBiogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
ZacksEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.